)
)
Transforming care pathways: essential to the long-term conditions revolution
Join NHS leaders and AstraZeneca in an interactive session to explore pathway redesign and transformative care initiatives that improve the identification, diagnosis, and treatment of long-term conditions. Hear about case studies and insights and engage in dialogue to start to think whether this may be appropriate for your health system. This session aims to drive a strategic shift towards preventive care, offering a collaborative platform for extracting practical solutions and fostering innovation in healthcare management.
This session is sponsored by AstraZeneca UK.
GB-66382
April 2025
Sponsored by:
